76 related articles for article (PubMed ID: 32551883)
1. COVID-19 and the Drug Repurposing Tsunami.
Mucke HAM
Assay Drug Dev Technol; 2020 Jul; 18(5):211-214. PubMed ID: 32551883
[No Abstract] [Full Text] [Related]
2. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
Abbasi J
JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
[No Abstract] [Full Text] [Related]
3. Chloroquine for Covid 19: introducing drug repurposing to medical students.
Koren G; Korn L
Int J Med Educ; 2020 Jul; 11():155-157. PubMed ID: 32712597
[No Abstract] [Full Text] [Related]
4. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
5. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
Martin JH; Bowden NA
Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
[No Abstract] [Full Text] [Related]
6. COVID-19: A Defining Moment for Clinical Pharmacology?
van der Graaf PH; Giacomini KM
Clin Pharmacol Ther; 2020 Jul; 108(1):11-15. PubMed ID: 32350861
[No Abstract] [Full Text] [Related]
7. Propofol and SARS-CoV-2 infection.
Hirota K; Lambert DG
Br J Anaesth; 2020 Dec; 125(6):e475-e476. PubMed ID: 32928516
[No Abstract] [Full Text] [Related]
8. Cationic drugs and COVID-19.
Brenna OV; Torretta S; Pignataro L; Di Berardino F
Int J Immunopathol Pharmacol; 2020; 34():2058738420966078. PubMed ID: 33045858
[TBL] [Abstract][Full Text] [Related]
9. Re-tasking the use of pre-existing medications and potential therapeutic options for coronavirus disease (COVID-19): systematic review of clinical studies.
Marouf BH; Dizaye K
Drug Discov Ther; 2020; 14(3):109-116. PubMed ID: 32669519
[TBL] [Abstract][Full Text] [Related]
10. Teaching Old Drugs New Tricks: Statins for COVID-19?
Fajgenbaum DC; Rader DJ
Cell Metab; 2020 Aug; 32(2):145-147. PubMed ID: 32755604
[TBL] [Abstract][Full Text] [Related]
11. Psychiatry and COVID-19: The Role of Chlorpromazine.
Stip E
Can J Psychiatry; 2020 Oct; 65(10):739-740. PubMed ID: 32536208
[No Abstract] [Full Text] [Related]
12. The pandemic pipeline.
Hodgson J
Nat Biotechnol; 2020 May; 38(5):523-532. PubMed ID: 32203293
[No Abstract] [Full Text] [Related]
13. The pandemic's first major research scandal erupts.
Servick K; Enserink M
Science; 2020 Jun; 368(6495):1041-1042. PubMed ID: 32499418
[No Abstract] [Full Text] [Related]
14. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
15. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Martinez MA
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
[TBL] [Abstract][Full Text] [Related]
16. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
[TBL] [Abstract][Full Text] [Related]
17. Big studies dim hopes for hydroxychloroquine.
Kupferschmidt K
Science; 2020 Jun; 368(6496):1166-1167. PubMed ID: 32527806
[No Abstract] [Full Text] [Related]
18. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges.
Singh H; Kakkar AK; Chauhan P
Expert Rev Anti Infect Ther; 2020 Oct; 18(10):997-1003. PubMed ID: 32552044
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
Naghipour S; Ghodousi M; Rahsepar S; Elyasi S
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
